Single‐Dose Pharmacokinetic Assessment of TNX‐102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open‐Label Studies in Healthy Volunteers
Clinical Pharmacology in Drug Development · Published 2026-02-26 · DOI 10.1002/cpdd.70034
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.1002/cpdd.70034
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Related articles
- Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers · Clinical Pharmacology in Drug Development · 2026 · Same journal
- Distributed Manufacturing, Foreign Establishments, and Why the FDA's New Proposed Rule Matters to Clinical Pharmacology · Clinical Pharmacology in Drug Development · 2026 · Same journal
- Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers · Clinical Pharmacology in Drug Development · 2026 · Same journal
- Pharmacokinetics and Bioequivalence of Tamsulosin Hydrochloride Extended‐Release Capsules in Healthy Chinese Volunteers: A Randomized, Open‐Label, Crossover Study Under Fasting and Fed Conditions · Clinical Pharmacology in Drug Development · 2026 · Same journal
- Pharmacokinetic Interaction Between Atorvastatin and Hybutimibe in Healthy Chinese Volunteers · Clinical Pharmacology in Drug Development · 2026 · Same journal
- From Reflection to Acceleration: Clinical Pharmacology’s 2025 Lessons and 2026 Opportunities · Clinical Pharmacology in Drug Development · 2026 · Same journal
- Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open‐Label, Parallel‐Group Study · Clinical Pharmacology in Drug Development · 2026 · Same journal
- Pharmacokinetics and Safety of VV116 in Subjects With Mild or Moderate Hepatic Impairment Compared With Healthy Controls: A Phase I, Open‐Label Study · Clinical Pharmacology in Drug Development · 2026 · Same journal
- A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers · Clinical Pharmacology in Drug Development · 2026 · Same journal
- Pharmacokinetic Evaluation of a Fixed‐Dose Combination of Pelubiprofen and Tramadol: A Randomized Crossover Relative Bioavailability Trial and a Fixed‐Sequence Food‐Effect Study in Healthy Volunteers · Clinical Pharmacology in Drug Development · 2026 · Same journal